Aksoy, S. Et Al. 2018. MicroRNA dysregulation as a prognostic biomarker in wild-type RAS/RAF/PTEN/PI3 metastatic colon cancer treated with anti-EGFR therapeutics. International Congress on Targeted Anticancer Therapies (TAT) , (Paris, France).

Aksoy, S., Kanat, O., Tunca, B., Ertas, H., Ugras, N., Ozturk, E., ... Yilmazlar, T.(2018). MicroRNA dysregulation as a prognostic biomarker in wild-type RAS/RAF/PTEN/PI3 metastatic colon cancer treated with anti-EGFR therapeutics . International Congress on Targeted Anticancer Therapies (TAT), Paris, France

Aksoy, S. Et Al. "MicroRNA dysregulation as a prognostic biomarker in wild-type RAS/RAF/PTEN/PI3 metastatic colon cancer treated with anti-EGFR therapeutics," International Congress on Targeted Anticancer Therapies (TAT), Paris, France, 2018

Aksoy, S. Et Al. "MicroRNA dysregulation as a prognostic biomarker in wild-type RAS/RAF/PTEN/PI3 metastatic colon cancer treated with anti-EGFR therapeutics." International Congress on Targeted Anticancer Therapies (TAT) , Paris, France, 2018

Aksoy, S. Et Al. (2018) . "MicroRNA dysregulation as a prognostic biomarker in wild-type RAS/RAF/PTEN/PI3 metastatic colon cancer treated with anti-EGFR therapeutics." International Congress on Targeted Anticancer Therapies (TAT) , Paris, France.

@conferencepaper{conferencepaper, author={S. Aksoy Et Al. }, title={MicroRNA dysregulation as a prognostic biomarker in wild-type RAS/RAF/PTEN/PI3 metastatic colon cancer treated with anti-EGFR therapeutics}, congress name={International Congress on Targeted Anticancer Therapies (TAT)}, city={Paris}, country={France}, year={2018}}